Personalising whole genome sequencing doubles diagnosis of rare diseases
Drug Discovery World
NOVEMBER 7, 2022
To do so, they tested how using a genomic medicine team of specialist doctors, bioinformaticians, and scientists could boost the capabilities of NHS diagnostic laboratories beyond the standard semi-automated analysis of data. . It can also permit targeted screening of known disease complications and access to drug studies.
52 
Let's personalize your content